AI-generated summary
The authors studied a 308-nm excimer laser for localized vitiligo in Asian patients, treating patches twice weekly for up to 13 weeks in a controlled prospective trial. They report the treatment was effective and relatively safe, with face lesions responding better than hands and feet. Results were judged by clinical assessment and photo comparison by two investigators.
- Participants
- 34
- Who or what was studied
- Asian patients with localized vitiligo (34 enrolled, 29 completed; 14 males and 20 females enrolled)
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract does not describe a control group beyond untreated patches, and response was assessed by investigator comparison rather than a stated objective measure.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.